Paradoxical Reaction to Golimumab: Tumor Necrosis Factor α Inhibitor Inducing Psoriasis Pustulosa
Importance: Golimumab is a human monoclonal antibody, used for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Adverse reactions are increasing with this class of medication (tumor necrosis factor α inhibitors). Observations: The authors present a case of a female patient who p...
Saved in:
Main Authors: | Marien Siqueira Soto Lopes (Author), Beatriz Moritz Trope (Author), Maria Paula Rua Rochedo Rodriguez (Author), Rachel Lima Grynszpan (Author), Tullia Cuzzi (Author), Marcia Ramos- (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2013-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Case of Paradoxical Reactions to Biologic Therapy for Psoriasis
by: Zhou Q, et al.
Published: (2023) -
Possible Paradoxical Photosensitive Psoriasis Induced by Tumour Necrosis Factor-alpha Inhibitors
by: Pauline Bataille, et al.
Published: (2019) -
GOLIMUMAB - A NEW TNF α-BLOCKER. THE REVIEW OF THE EFFICACY AND SAFETY EVALUATION RESULTS
by: R. V. Denisova, et al.
Published: (2012) -
Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?
by: Zuzana Jiraskova Zakostelska, et al.
Published: (2023) -
DNA Copy Number Variation Associated with Anti-tumour Necrosis Factor Drug Response and Paradoxical Psoriasiform Reactions in Patients with Moderate-to-severe Psoriasis
by: Ancor Sanz-Garcia, et al.
Published: (2021)